| Current dividend yield | 4.05 % |
| Dividendenrendite 5 Jahre | 8.58 % |
| Dividend Yield 10Y | 1.21 % |
| Payout 3Y | 4.0 % |
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2016 |
$29.1
$29.1
|
Feb 06 2017
Feb 06 2017
Feb 03 2017
Feb 06 17
Feb 03 17 |
Feb 03 2017 |
Special dividend
Special div.
|
Altimmune, Inc. most recently paid a dividend of $29.10. Altimmune, Inc. paid a Dividend of $0.00 Per Share in the financial year 2024. With a stock price of $4.59 at Nov 19 2025, the current dividend yield is 0.00% (calculation: $0.00 / $4.59 = 0.00%). No special dividend was paid.
The average Altimmune, Inc. dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.00%.
The payout ratio of Altimmune, Inc. in relation to the last financial year is 0.00%. The payout ratio smoothed over 3 years is 0.00%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | Altimmune, Inc. |
|---|---|
| Current dividend yield | 0.00% |
| Dividend Yield 5Y | 0.00% |
| Dividend Yield 10Y | 0.00% |
| Payout 1Y | 0.00% |
| Payout 3Y | 0.00% |
Altimmune, Inc. has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
| Metric | Altimmune, Inc. |
|---|---|
| Increased | 0 Years |
| Continuity | 0 Years |
| Paid | 0 Years |
Altimmune, Inc. has been paying a dividend for 0 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
On the stock exchange, the Altimmune, Inc. stock (ISIN: US02155H1014) is not traded as a top scorer in November 2025 according to the dividend strategy.
The stock price of Altimmune, Inc. -36.34% has fallen since the beginning of the year 2025. However, the return generated in the past says nothing about the future return. You can find the Altimmune, Inc. stock price in real time at the top of the page.
Altimmune, Inc. (symbol: ALT) is valued at a Price / Earnings Ratio (P/E ratio) of -4.94 and a price/sales ratio (P/S ratio) of 23,946.58 valued. Based on analyst estimates, the Altimmune, Inc. stock forecast 2025 of the current financial year corresponds to a valuation of -4.09 according to P/E ratio and 84,225.24 according to P/S.
| Metric | Altimmune, Inc. |
|---|---|
| Dividend Score | ??/15 |
| Performance 2025 |
36.34%
|
| P/E TTM | -4.94 |
| P/S TTM | 23,946.58 |
| P/E forward | -4.09 |
| P/S forward | 84,225.24 |
Altimmune, Inc. (symbol: ALT) is valued at a Price / Earnings Ratio (P/E ratio) of -4.94 and a price/sales ratio (P/S ratio) of 23,946.58 valued. Based on analyst estimates, the Altimmune, Inc. stock forecast 2025 of the current financial year corresponds to a valuation of -4.09 according to P/E ratio and 84,225.24 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


